Intravenous Efgartigimod Alfa as Initial Monotherapy for Disabling Ocular Myasthenia in an Elderly Patient with Multiple Comorbidities

Publication Date

2024

Content Type

article

PubMed ID:

39734968

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS